Trials / Terminated
TerminatedNCT00939042
Alster Stem Cells - Intramyocardial Stem Therapy
Percutaneous Intramyocardial Cell Therapy After Acute Myocardial Infarction Using Bone Marrow Mononuclear Cells
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Asklepios proresearch · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Study to assess the efficacy of intramyocardial bone marrow derived mononuclear cell therapy concerning left ventricular ejection fraction as measured by echocardiography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous Coronary Intervention | common Percutaneous Coronary Intervention |
| PROCEDURE | BMNC therapy | Injection of BMNC after common PCI |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2009-07-14
- Last updated
- 2022-10-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00939042. Inclusion in this directory is not an endorsement.